Nuclear chemistry

Coty Names Dr. Shimei Fan as Chief Scientific Officer

Retrieved on: 
Tuesday, November 16, 2021

Coty, Inc. (NYSE: COTY) today announced that Dr. Shimei Fan, formerly Senior Vice President of Shiseidos Americas Innovation Center, will join the company as Chief Scientific Officer, reporting to CEO Sue Y. Nabi.

Key Points: 
  • Coty, Inc. (NYSE: COTY) today announced that Dr. Shimei Fan, formerly Senior Vice President of Shiseidos Americas Innovation Center, will join the company as Chief Scientific Officer, reporting to CEO Sue Y. Nabi.
  • As Chief Scientific Officer, Shimei will head up the 500 employees in the organizations global R&D and innovation function and lead on sustainability.
  • Coty is leading the field of 'Clean Beauty That Works', and with Shimei as Chief Scientific Officer leading on sustainability, we are demonstrating our belief that sustainability is the ultimate driver of beauty innovation and central to Cotys continued success.
  • Her appointment as Cotys Chief Scientific Officer, whose R&D responsibilities were previously held by the Chief Supply Officer and Head of R&D, reflect Cotys belief that sustainability-driven innovation is the key to the companys continued and future success.

Helion Energy Breaks Ground on Site of Its Next-Generation Fusion Facility in Everett, Washington

Retrieved on: 
Tuesday, July 27, 2021

Helion Energy (Helion), a clean energy company committed to creating a new era of zero-carbon electricity through fusion, today broke ground on the next iteration of its fusion facility in Everett, Washington.

Key Points: 
  • Helion Energy (Helion), a clean energy company committed to creating a new era of zero-carbon electricity through fusion, today broke ground on the next iteration of its fusion facility in Everett, Washington.
  • The new facility will accelerate Helions efforts to build the worlds first commercially-viable fusion power plant.
  • (Photo: Business Wire)
    Washington is proud to be the home of world-leading pioneers developing affordable, clean energy solutions, said Governor Jay Inslee.
  • With this new facility, Helion and Washington are taking game-changing action to address the climate crisis.

Plus Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights

Retrieved on: 
Thursday, July 22, 2021

); Conference ID: PSTVQ221

Key Points: 
  • ); Conference ID: PSTVQ221
    The webcast can be accessed live via the investor section of the Plus Therapeutics website at ir.plustherapeutics.com/events and will be available for replay beginning two hours after the conclusion of the conference call.
  • Plus Therapeutics is a clinical-stage pharmaceutical company whose radiotherapeutic portfolio is concentrated on nanoliposome-encapsulated radionuclides for several cancer targets.
  • Central to the Companys drug development is a unique nanotechnology platform designed to reformulate, deliver and commercialize multiple drugs targeting rare cancers and other diseases.
  • There may be events in the future that the Company is unable to predict, or over which it has no control, and its business, financial condition, results of operations and prospects may change in the future.

NASA Announces Nuclear Thermal Propulsion Reactor Concept Awards

Retrieved on: 
Tuesday, July 13, 2021

The government teamhas selected three reactor design concept proposals for a nuclear thermal propulsion system.

Key Points: 
  • The government teamhas selected three reactor design concept proposals for a nuclear thermal propulsion system.
  • The reactor is a critical component of a nuclear thermal engine, which would utilize high-assay low-enriched uranium fuel.
  • "INL is excited to enable the development of nuclear propulsion technology for potential use by NASA in future space exploration," said Dr. Stephen Johnson, national technical director for space nuclear power and director of the Space Nuclear Power and Isotope Technologies Division at INL.
  • Maturing fission surface power can also help inform nuclear electric propulsion systems, another candidate propulsion technology for distant destinations.

Bechtel-led team awarded contract extension for Sellafield Pile Fuel Cladding Silo project in the UK

Retrieved on: 
Friday, June 25, 2021

RESTON, Va., June 25, 2021 /PRNewswire/ -- Sellafield Ltd. has awarded Bechtel Cavendish Nuclear Solutions a two-year contract extension and added work to the Pile Fuel Cladding Silo project at the UK's Sellafield Site in northern England.

Key Points: 
  • RESTON, Va., June 25, 2021 /PRNewswire/ -- Sellafield Ltd. has awarded Bechtel Cavendish Nuclear Solutions a two-year contract extension and added work to the Pile Fuel Cladding Silo project at the UK's Sellafield Site in northern England.
  • The waste consists of 3,200 cubic meters of radioactive cladding pieces of metal tubes used for uranium fuel rods in some of the UK's earliest nuclear reactors.
  • The mission of the PFCS project is to deliver a system that allows Sellafield to retrieve the waste, package it safely, and dispose of it permanently.
  • "I am incredibly proud of our collective team, who thoroughly deserve the trust placed in them."

Global Nuclear Medicine Radioisotope Markets 2021-2027: Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Others - Technetium-99m (Tc-99m) to Account for $24.8 Billion - ResearchAndMarkets.com

Retrieved on: 
Monday, May 31, 2021

World Current & Future Analysis for Nuclear Medicine Radioisotope by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR

Key Points: 
  • World Current & Future Analysis for Nuclear Medicine Radioisotope by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR
    World Historic Review for Nuclear Medicine Radioisotope by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
    World 15-Year Perspective for Nuclear Medicine Radioisotope by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2018 & 2027
    World 15-Year Perspective for Technetium-99m (Tc-99m) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
    World 15-Year Perspective for Thallium-201 (Tl-201) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
    World 15-Year Perspective for Iodine (I-123) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
    World 15-Year Perspective for Gallium-67 (Ga-67) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
    World 15-Year Perspective for Other Type of Radioisotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
    World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
    World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
    World 15-Year Perspective for Lymphoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
    World 15-Year Perspective for Thyroid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
    World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027

Arcadia Biosciences (RKDA) Signs Hemp Distribution Agreement with Tritium 3H

Retrieved on: 
Tuesday, November 24, 2020

Said Arcadia CEO Matt Plavan, "This agreement solidifies our plans to accelerate the commercialization of Arcadia's hemp genetics internationally and affirms market demand for our portfolio of superior GoodHemp varieties.

Key Points: 
  • Said Arcadia CEO Matt Plavan, "This agreement solidifies our plans to accelerate the commercialization of Arcadia's hemp genetics internationally and affirms market demand for our portfolio of superior GoodHemp varieties.
  • We're proud to partner with a well-respected distributor like Tritium 3H to bring our CBD dominant, short day varieties to Canada's industrial hemp growers."
  • Tritium 3H works collaboratively with breeders, producers and end users to bring well adapted hemp varieties with superior performance traits to market.
  • These forward-looking statements speak only as of the date hereof, and Arcadia Biosciences, Inc. undertakes no duty to update these forward-looking statements.

LIVE TELECAST FOR World Children's Day: Unveil the future artificial sun with scientists from China and Russia on November 20!

Retrieved on: 
Friday, November 20, 2020

But, even clean energies, including wind energy, solar energy and tidal energy, do not spare humanity worries.

Key Points: 
  • But, even clean energies, including wind energy, solar energy and tidal energy, do not spare humanity worries.
  • This brings them to a bold hypothesis: By polymerizing hydrogen isotopes into helium, inexhaustible fusion energy will be released.
  • Scientists from both countries will be invited to elaborate on the artificial sun and on the hard realization of controllable nuclear fusion.
  • We believe that the light of fusion will be lit early with the efforts of the scientists in both countries.

LIVE TELECAST FOR World Children's Day: Unveil the future artificial sun with scientists from China and Russia on November 20!

Retrieved on: 
Friday, November 20, 2020

But, even clean energies, including wind energy, solar energy and tidal energy, do not spare humanity worries.

Key Points: 
  • But, even clean energies, including wind energy, solar energy and tidal energy, do not spare humanity worries.
  • This brings them to a bold hypothesis: By polymerizing hydrogen isotopes into helium, inexhaustible fusion energy will be released.
  • Scientists from both countries will be invited to elaborate on the artificial sun and on the hard realization of controllable nuclear fusion.
  • We believe that the light of fusion will be lit early with the efforts of the scientists in both countries.

The Rise of Virtual Offices, New Technology Hubs & Automated Recruitment Tools Lead Nucleus Research’s Top 10 Technology Predictions for 2021

Retrieved on: 
Wednesday, October 21, 2020

Our 2021 predictions reflect the latest trends that we expect will impact our clients in the coming year, said Ian Campbell, CEO of Nucleus Research.

Key Points: 
  • Our 2021 predictions reflect the latest trends that we expect will impact our clients in the coming year, said Ian Campbell, CEO of Nucleus Research.
  • Nucleus Researchs top 10 predictions for 2021 look at opportunities and pitfalls based on the numbers that drive business.
  • For the past 17 years, Nucleus annual technology predictions have been 94 % accurate unmatched by any other leading technology prognosticator based on the firms analysis and application of historical data.
  • For the full 2021 Technology Predictions report, visit: https://nucleusresearch.com/research/single/nucleus-top-ten-predictions-...
    Nucleus Research is a global provider of investigative, case-based technology research and advisory services.